Nevin Bradford, CEO of CiplaQCIL. He says regardless of the negative impact of Covid-19 towards businesses in the country, the company was focused on driving shareholder value through increased revenues and profitability
Leading Pharmaceutical manufacturer CIPLAQCIL has announced the acquisition of assets of Quality Chemical’s Limited’s Human health care business portfolio in a deal worth US$ 1.27 million (UGX4.6 billion). In a statement to the public and its shareholders, the company said the deal which will see transfer of human business assets, including sales staff, is expected to boost the company’s

Thank You For Reading CEO East Africa Magazine.

Please SUBSCRIBE for UNLIMITED ACCESS to our game-changing stories or LOG IN for existing members.

Tagged: